Chernobyl, 25 Years Later: Lessons for Japan?

April 27, 2011

On the 25th anniversary of the Chernobyl nuclear disaster, a comment published by Lancet Oncology describes the known health consequences of the 1986 event. The authors are Kirsten B. Moysich, PhD, MS, and Philip McCarthy, Jr., MD, both of Roswell Park Cancer Institute (RPCI), and Per Hall, PhD, of Karolinska Institute, Stockholm, Sweden — who have contributed to numerous scholarly articles on this topic, including the first major United Nations Report into the effects of the Chernobyl accident in 2000.

Dr. Moysich is Professor of Oncology in the Department of Prevention and Control and Professor and Academic Program Chair of the Department of Cancer Pathology and Prevention at RPCI, and Dr. McCarthy is a Professor of Oncology and Director of the Institute’s Blood & Marrow Transplant Program.

The authors point out that there were many obstacles in studying the aftermath of the Chernobyl accident and that the Fukushima incident might offer a new, albeit sad, opportunity to more accurately study the of a major nuclear-power-plant accident. The authors attribute this to the greater scientific expertise in Japan, as well as the greater economic and political stability.

Radioactive elements with a long half-life (the time it takes for half the sample to decay), especially caesium and strontium, will be prevalent in the environment for decades to come. Radioactive iodine, despite having a half-life of just eight days, can cause damage by being absorbed into the body through food, where it is stored in the thyroid gland. An increased risk of childhood thyroid cancer (3 to 8 times higher) among those with the highest exposures was seen post-Chernobyl in affected areas. This has led to recommendations to distribute potassium iodine tablets to children and adolescents in the most contaminated areas following a nuclear-power-plant accident. Unfortunately, no chemoprotective interventions are available for radiation exposure from caesium or strontium. The authors say: “Aggressive efforts will be needed to limit exposure to radioactive iodine and caesium, and to isolate contaminated areas. In particular, children and young adults are at highest risk because of past data showing that exposure at young ages increases the risk of adverse health effects such as thyroid cancer.”

They also discuss the potential harmful effect of radiation for girls in puberty. Evidence from the Japanese Life Span Study (which looked at radiation related risk factors following detonation of atomic bombs in World War II) suggested that the highest excess risk for breast cancer was for women who were in puberty at the time of the atomic bombing. The authors say: “Another sensitive time-point is lactation at the time of the accident, when the likelihood of radionuclide absorption to the mammary tissue is high.”

Dr. Moysich and colleagues conclude that the documented cancer consequences of the Chernobyl accident were restricted to thyroid cancer in children and were much lower than first expected. Due to the many issues associated with studying Chernobyl health effects, results from new studies focusing on the Fukushima incident might uncover more accurate estimates of the aftermath of nuclear power plant accidents in the past and present, as well as provide useful information for the public health management of future events.

More information: For more information, visit www.thelancet.com/journals/lan … (11)70095-X/abstract

Related Stories

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.